Navigation Links
Selecta II Glaucoma Laser System

ProductsSelecta II Glaucoma Laser System
Company Lumenis Inc.
Item Selecta II Glaucoma Laser System
Features Q-switch produces short pulses of low energy laser light. Selectively targets pigmented cells, increasing fluid outflow. Eliminates burns that scar trabecular meshwork. Economical and efficient, treatment is performed in the physician's office.
Description The Selecta II Glaucoma Laser System is a Q-switched 532 Nd Yag laser selectively targets pigmented cells and increases fluid output, lowering intraocular pressure. The Selecta II is equipped with a Q-switch that produces a 3-nanosecond high-energy beam of light, which induces the same cell replacement mechanism as traditional argon laser therapy (ALT), but without the burn. The short pulse of the laser does not allow time for heat to spread to other cells.
Info Lumenis Inc.
Customer Service: 877-lumenis
Web site: http://www.lumenis.com

Related medicine products :

1. Selecta II Glaucoma Laser System
2. Selecta Duet
3. Selecta 1064 nm Nd:YAG Base Platform
4. Selecta Duo Photocoagulator Combination Laser
5. Selecta Trio Photocoagulator and SLT Combination Laser
6. Baerveldt Glaucoma Implant
7. Baerveldt Pars Plan Glaucoma Implant
8. Ahmed Glaucoma Valve
9. Ahmed Glaucoma Valve Flexible Plate
10. Ahmed Glaucoma Valve (small size)
11. Ahmed Glaucoma Valve with Pars Plana Clip
Safety Blood Collection Sets are supplied in three packaging variations, either with or without Luer Adapter and respectively a version with Luer Adapter and Tube Holder....
... The Omni-Flex System provides ... arms in the middle of ... tension on the incision. The ... to be stable for large ...
These retractors are packaged singly ready for sterilization at your facility....
... revolutionary motorized electronic pipette. Conceived with ... Concept features exclusive multifunction characteristics and ... of its kind in the industry. ... Gilson, this product will maximize performance ...
Medicine Products:
(Date:4/24/2017)... ... ... Pink , a national non-profit organization focusing on the prevention and early detection of breast ... proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay ... the Board and launched a national search to find a visionary new leader to grow ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP ... food supplements, announced its popular products are now available for purchase on StackedNutrition.com, ... prioritizes the use of premium natural ingredients in making all of its products. ...
(Date:4/24/2017)... NEW PORT RICHEY, Fla. (PRWEB) , ... April ... ... Disease Control and Prevention (CDC), rising prescription opioid overdose deaths now claim the ... (DEA) has slashed its civil case filings against drug manufacturers, distributors, pharmacies and ...
(Date:4/24/2017)... ... 2017 , ... As a former supermodel known for her timeless beauty, Joan ... single women is that she put all the words in her new book, "Manifest ... personal experiences and sparkling sense of humor have inspired her to write a book ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each ... published author, Jerri Broglin, a survivor of great loss who gained insight on how ... for those searching for answers, as we are finding the answers that are so ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton ... Edward Wright , Chief Executive Officer of the Company is scheduled ... CFO, Richard Bear and the Chairman of the Board, ... ...
(Date:4/19/2017)... Global Surgical Drainage Device Market: Overview ... remove excess liquid and air. The fluid to be ... lymph. Surgical drains are used in a wide variety ... cardiovascular surgery, neurosurgery, plastic surgery etc. Common use of ... of fluid e.g. blood or pus. Surgical drains are ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
Breaking Medicine Technology: